首页> 外文期刊>Journal of biomaterials and tissue engineering >Fabrication and Characterization of Three-Dimensional Scaffold with Multiscale Vascularized Channels for Tissue Engineering Using a Novel Composite Forming Technique
【24h】

Fabrication and Characterization of Three-Dimensional Scaffold with Multiscale Vascularized Channels for Tissue Engineering Using a Novel Composite Forming Technique

机译:用新型复合材料成形技术用多尺度血管化通道的三维支架的制造与表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Despite significant progress has been made in tissue engineering scaffolds over the past decade, there are still many challenges. One of the greatest challenges is the lack of effective construction of Vascularized Channels that conforms to human tissue on a three-dimensional (3D) tissue engineering scaffold structure. This limits the ability of the scaffold to provide oxygen and nutrients to cells. In this work, we use a novel composite forming technique combined Three-dimensional (3D) bioprinting with electrohydrodynamic (EHD) jet printing by using two sacrificial materials to prepare a tissue scaffold with multiscale vascularized Channels. Pluronic F127 is used to print the primary and secondary networks of the sacrificial template, polycaprolactone (PCL) is used to print the microscopic network of sacrificial templates, and the receiving platform is a modified gelatin-printed hemisphere structure that allows the sacrificial template to have a complex 3D structure. The sacrificial template can be removed by a temperature-controlled and water bath to obtain a tissue scaffold with a 3D vascular access. Inoculation experiments with human umbilical vein endothelial cells (HUVEC) indicate that the manufacturing process is biocompatible with cells.
机译:尽管在过去十年中,在组织工程脚手架中取得了重大进展,但仍存在许多挑战。最大的挑战之一是缺乏有效的血管化通道建造,符合人类组织对三维(3D)组织工程支架结构的人体组织。这限制了支架为细胞提供氧气和营养物质的能力。在这项工作中,我们使用一种新的复合成形技术,通过使用两个牺牲材料来使用电液动力学(EHD)喷射印刷的三维(​​3D)生物印刷,以制备具有多尺度血管化通道的组织支架。 Pluronic F127用于打印牺牲模板的初级和二级网络,使用多己内酯(PCL)来打印牺牲模板的微观网络,并且接收平台是改性明胶印刷的半球结构,允许牺牲模板具有复杂的3D结构。可以通过温度控制和水浴除去牺牲模板,以获得具有3D血管进入的组织支架。与人脐静脉内皮细胞(HUVEC)接种实验表明制造过程与细胞生物相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号